Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
16.10
+0.32 (2.03%)
Oct 31, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Microbiome Therapeutics
126.33M
Log In
Log In
Log In
Log In
Upgrade
Microbiome Therapeutics Growth
1672.24%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
126.33M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1672.24%
Log In
Log In
Log In
Log In
Upgrade